TRU-SENTIMENT · DeltaNeutral

LLY Trading Analysis - 08/19/2026 12:28 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

LLY (Eli Lilly & Co.) at $1269.85. True Sentiment Bullish, delta 40-60 call 80% / put 20%, call $327,715 vs put $84,616. RSI 67.9.

Symbol: LLY
Price: $1269.85
Article bias (separate from True Sentiment): bullish
Conviction: medium
Published: 2026-08-19 12:28:00 ET
Author: DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options):

Call dollar volume: $327,715.4

Put dollar volume: $84,615.85

Call/put ratio: 79.5%/20.5%, indicating bullish sentiment.

Key Statistics: LLY

$1,225.73 +0.00%

52-Week Range

$685.15 - $1,292.65

Market Cap

$2.20T

P/E (TTM)

41.15

PEG Ratio

N/A

Beta

N/A

Next Earnings

N/A

Avg Volume

$3.30M

Dividend Yield

N/A

Fundamental Snapshot

Valuation

P/E (Trailing)	41.15
P/E (Forward)	N/A
PEG Ratio	N/A
Price/Book	64.88

Profitability

EPS (Trailing)	$29.79
EPS (Forward)	N/A
ROE	78.84%
Net Margin	33.53%

Financial Health

Revenue (TTM)	$79.67B
Debt/Equity	3.20
Free Cash Flow	N/A
Rev Growth	N/A

Analyst Consensus

None

Target: $N/A

Based on None Analysts

📈 Analysis

News Headlines & Context:

X/Twitter Sentiment (live xAI x_search, cited only):

User	Post	Sentiment	Time	Link
Freedom_Stocks	⚠️ $PFE This was on the Freedom Radar before the move.\n\n📈 The setup eventually traded nearly +35% from the original radar.\n\n📲Everyone manages exits differently.\n\n📡Like this post to jump on board $LLY $NVO $BMY	Bullish	Tue, 18 Aug 2026 23:39:06 GMT	https://x.com/Freedom_Stocks/status/2089859664129167474
azrael_options	Final trade mix with $LLY and $NFLX is a classic rotation hedge.\n\nDealer delta from those calls keeps the index bid but only until the bell; after that the gamma flip drags.	Neutral	Tue, 18 Aug 2026 23:36:23 GMT	https://x.com/azrael_options/status/2089858980658979165
TexasTrade7	$LLY up 3% on continued investor enthusiasm around its obesity-drug franchise after its recent earnings beat and raised full-year revenue outlook showed exceptionally strong demand for Mounjaro and Zepbound.	Bullish	Tue, 18 Aug 2026 23:36:08 GMT	https://x.com/TexasTrade7/status/2089858916339667354
moneymaker7723	CNBC “Halftime Report” final trades 8/18\n\nBryn Talkington - Horizon Kinetics Inflation Beneficiaries ETF $INFL \nStephanie Link - Elanco Animal Health $ELAN \nJoe Terranova - Eli Lilly $LLY \nJason Snipe - Netflix $NFLX	Neutral	Tue, 18 Aug 2026 23:33:33 GMT	https://x.com/moneymaker7723/status/2089858269393150106
twinsight_x	Aug 18 Trade Recap 🔥\n\n@mataetrades\n$AMD 480P 4.05 -> 6.42 (+59%)\n$SPX 7720C failed\n\n@tradersarangc\n$SPX 7705C 3.15 -> 4.65 (+48%)\n$AVGO 380P 4.83 -> 7.15 (+48%)\n$LLY 1250C 5.15 -> 6.15 (+19%)	Bullish	Tue, 18 Aug 2026 23:23:57 GMT	https://x.com/twinsight_x/status/2089855850898665585
NQGODTRADES	S&P 500 Update: Wall Street trapped Retail ( The drop was called lastnight go fact check the last video) QQQ/Spy Levels for tomorrow -> https://www.youtube.com/watch?si=yMa9W_TfYDTpYaAb&v=9UoRJ9roPv4&feature=youtu.be via @YouTube $SNDK $PLTR $AMD $SPCX $LLY $COP $ANET $QBTS $WDC $APP $OKLO $SHOP $PFE $ALAB $CAT $DDOG $UBER $ELF $CELH $TTMI $STRL $RDW $ZETA $AXON $MELI $DIS $BYND $DKNG $DIBS $OPEN $UUUU $VST $BKNG $TXG $ABNB $FSLY $RIOT $AAOI $RGTI $HIMX $CENX $ALB $MCD $HUT $W $INOD $CLX $BROS $KTOS	Neutral	Tue, 18 Aug 2026 23:18:30 GMT	https://x.com/NQGODTRADES/status/2089854478883164639
nolphy_01	I' created a dedicated WhatsApp group for $IAUX $TME $LLY shareholders and active traders to connect, share insights, and get tI' latest updates.\n\nLet's discuss stock market trends.\n\n 🔗https://hihello.com/p/b145e8c9-a47b-4959-ad02-b4e13135cc71\n\nClick this link or the link on my homepage to join	Neutral	Tue, 18 Aug 2026 23:18:20 GMT	https://x.com/nolphy_01/status/2089854437817008626
IBZNU	Good day for $LLY	Bullish	Tue, 18 Aug 2026 22:57:38 GMT	https://x.com/IBZNU/status/2089849229158339054

Summary: Posts highlight $LLY gains from obesity drug demand, positive trading recaps, and mentions in CNBC final trades.

Fundamental Analysis:

Based on the provided fundamentals:

Revenue: $79.6658B
Trailing EPS: $29.79
Trailing P/E: 41.15
Gross Margin: 0.834
Operating Margin: 0.422
Profit Margin: 0.335
Debt/Equity: 3.20
ROE: 0.788

LLY shows strong revenue and profit margins, with a high P/E ratio indicating potential overvaluation. The debt/equity ratio is relatively high, but ROE is strong.

Current Market Position:

Current price: $1269.55

Recent price action: Up 3% on strong demand for obesity drugs.

Technical Analysis:

SMA trends:

SMA 5: $1213.52
SMA 20: $1191.67
SMA 50: $1174.99

Price is above all SMAs, indicating bullish trend.

RSI 14: 67.92, above 50 but below 70, indicating moderate strength.

MACD: Bullish with $16.02 MACD and $12.81 signal.

Bollinger Bands: Price near upper band, indicating potential overbought.

True Sentiment Analysis (Delta 40-60 Options):

Call dollar volume: $327,715.4

Put dollar volume: $84,615.85

Call/put ratio: 79.5%/20.5%, indicating bullish sentiment.

Key Price Levels:

Support: $1174.99 (50-day SMA)

Resistance: $1292.65 (recent high)

25-Day Price Forecast:

LLY is projected for $1280.00 to $1400.00

Rationale: Based on current SMA trends, RSI momentum, MACD signals, and recent volatility (ATR).

Defined Risk Strategy Recommendations:

Based on the price forecast, consider:

Bull Call Spread: Buy $1280C, Sell $1320C
Iron Condor: Sell $1250C, Buy $1300C, Sell $1200P, Buy $1150P

Risk Factors:

Technical warning signs:

Potential overbought near upper Bollinger Band

Sentiment divergences:

None apparent

Volatility and ATR considerations:

Recent volatility may increase

Summary & Conviction Level:

Overall bias: Bullish

Conviction level: High

One-line trade idea: LLY shows strong bullish momentum with supportive technicals and sentiment.

🔗 View LLY Options Chain on Yahoo Finance

Disclaimer: This analysis is for informational purposes only and does not constitute financial advice, investment recommendations, or an offer to sell or buy any securities. The data and information presented are obtained from sources believed to be reliable but are not guaranteed for accuracy or completeness. Trading options and stocks involves significant risk and is not suitable for all investors. You should consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.